JS
Jacquelyn L Sumer
Chief Legal Officer

Jacquelyn L Sumer insider trades: Cullinan Therapeutics (CGEM) stock sales

Chief Legal Officer, Cullinan Therapeutics Last trade Feb 24, 2026 21 Form 4 filings
$137K
Sold, last 12 months
3 sales
$0
Bought, last 12 months
0 buys
12
Open-market trades
since 2022
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Jacquelyn reports to the SEC

Open-market buys and sales

12 trades reported on SEC Form 4, newest first

DateStockTypeValue
Feb 24, 2026CGEM↓ Sell$52K
Feb 20, 2026CGEM↓ Sell$51K
Dec 18, 2025CGEM↓ Sell$34K
Feb 25, 2025CGEM↓ Sell$32K
Dec 18, 2024CGEM↓ Sell$40K
Dec 21, 2023CGEM↓ Sell$12K
Dec 18, 2023CGEM↓ Sell$2K
Jun 20, 2023CGEM↓ Sell$4K
May 18, 2023CGEM↓ Sell$3K
Apr 18, 2023CGEM↓ Sell$3K
Mar 20, 2023CGEM↓ Sell$3K
Jun 1, 2022GNCA↓ Sell$150

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other CGEM insiders

Open-market trades in the last 12 months

About Jacquelyn L Sumer's insider trades

Jacquelyn L Sumer is Chief Legal Officer at Cullinan Therapeutics (CGEM). Since Jun 1, 2022, Jacquelyn has reported no open-market purchases and 12 sales worth $236K on SEC Form 4. In the last 12 months: 3 sales ($137K).

Their filings also include grants and awards (9 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CGEM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.